Literature DB >> 12844103

Transient exposure to elastase induces mouse aortic wall smooth muscle cell production of MCP-1 and RANTES during development of experimental aortic aneurysm.

Jamie S Colonnello1, Kirk A Hance, Murray L Shames, Charles W Wyble, Scott J Ziporin, Jeremy E Leidenfrost, Terri L Ennis, Gilbert R Upchurch, Robert W Thompson.   

Abstract

PURPOSE: Abdominal aortic aneurysm (AAA) is associated with chronic transmural inflammation and destruction of the elastic media. The purpose of this study was to elucidate molecular mechanisms that might orchestrate leukocyte recruitment into the outer aortic wall by determining whether CC chemokines contribute to development of aneurysm degeneration in an elastase-induced mouse model of AAA.
METHODS: Adult male C57BL/6J mice underwent transient elastase perfusion of the abdominal aorta to induce development of AAA. At various intervals after elastase perfusion (0, 4, 7, 14 days), real-time reverse transcription polymerase chain reaction and enzyme-linked immunosorbent assays were used to measure aortic wall expression of the CC (beta) chemokines, monocyte chemoattractant protein-1 (MCP-1) and regulated on activation, normal T-cell expressed and secreted (RANTES). Expression of these chemokines by cultured mouse aortic smooth muscle cells (AoSMC) was similarly assessed after transient (5 minutes) exposure to elastase solutions in vitro.
RESULTS: Mouse aortic diameter (mean +/- SEM) increased to aneurysmal proportions by 14 days after elastase perfusion (from 0.51 +/- 0.03 mm to 1.34 +/- 0.32 mm; 163% increase; P <.05), with macrophage infiltration of the outer aortic wall beginning within 7 to 10 days. Increased aortic wall messenger RNA expression for MCP-1 (28-fold) and RANTES (11-fold) was observed on day 4, with maximal production of chemokine protein on day 7 (MCP-1, from 7.07 +/- 0.06 ng/mL to 19.60 +/- 0.19 ng/mL; P <.001; RANTES, from 0.23 +/- 0.006 ng/mL to 2.03 +/- 0.057 ng/mL; P <.001). Neither MCP-1 nor RANTES was detected in normal mouse aorta with immunohistochemistry, but both chemokines were abundant in AAA. Within 48 hours of transient exposure to elastase, cultured mouse AoSMC exhibited pronounced induction (>90-fold) of MCP-1 and RANTES, despite concomitant decrease in cell numbers.
CONCLUSIONS: Increased mouse aortic wall expression of MCP-1 and RANTES occurs early in development of elastase-induced AAA and before onset of the chronic inflammatory response. Moreover, elastase directly stimulates AoSMC chemokine production in vitro. Elastase-induced medial SMC production of CC chemokines may therefore provide an important link between enzymatic injury, leukocyte recruitment, and aneurysmal degeneration of the aortic wall.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12844103     DOI: 10.1016/s0741-5214(03)00125-3

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  30 in total

Review 1.  Biomarkers of AAA progression. Part 1: extracellular matrix degeneration.

Authors:  Femke A M V I Hellenthal; Willem A Buurman; Will K W H Wodzig; Geert Willem H Schurink
Journal:  Nat Rev Cardiol       Date:  2009-05-26       Impact factor: 32.419

2.  A crosstalk triggered by hypoxia and maintained by MCP-1/miR-98/IL-6/p38 regulatory loop between human aortic smooth muscle cells and macrophages leads to aortic smooth muscle cells apoptosis via Stat1 activation.

Authors:  Qing Wang; Chang Shu; Jing Su; Xin Li
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

3.  Periadventitial adipose-derived stem cell treatment halts elastase-induced abdominal aortic aneurysm progression.

Authors:  Kory J Blose; Terri L Ennis; Batool Arif; Justin S Weinbaum; John A Curci; David A Vorp
Journal:  Regen Med       Date:  2014       Impact factor: 3.806

Review 4.  Macrophages in vascular inflammation--From atherosclerosis to vasculitis.

Authors:  Tsuyoshi Shirai; Marc Hilhorst; David G Harrison; Jörg J Goronzy; Cornelia M Weyand
Journal:  Autoimmunity       Date:  2015-03-26       Impact factor: 2.815

5.  Human mesenchymal stromal cell-derived extracellular vesicles attenuate aortic aneurysm formation and macrophage activation via microRNA-147.

Authors:  Michael Spinosa; Guanyi Lu; Gang Su; Sai Vineela Bontha; Ricardo Gehrau; Morgan D Salmon; Joseph R Smith; Mark L Weiss; Valeria R Mas; Gilbert R Upchurch; Ashish K Sharma
Journal:  FASEB J       Date:  2018-05-29       Impact factor: 5.191

6.  Pharmacologic inhibition of transient receptor channel vanilloid 4 attenuates abdominal aortic aneurysm formation.

Authors:  Alexander H Shannon; Craig T Elder; Guanyi Lu; Gang Su; Alexis Mast; Morgan D Salmon; William G Montgomery; Michael D Spinosa; Gilbert R Upchurch; Ashish K Sharma
Journal:  FASEB J       Date:  2020-06-07       Impact factor: 5.191

7.  Aortic implantation of mesenchymal stem cells after aneurysm injury in a porcine model.

Authors:  Irene C Turnbull; Lahouaria Hadri; Kleopatra Rapti; Mikel Sadek; Lifan Liang; Hyun J Shin; Kevin D Costa; Michael L Marin; Roger J Hajjar; Peter L Faries
Journal:  J Surg Res       Date:  2011-07-13       Impact factor: 2.192

8.  Experimental abdominal aortic aneurysm formation is mediated by IL-17 and attenuated by mesenchymal stem cell treatment.

Authors:  Ashish K Sharma; Guanyi Lu; Andrea Jester; William F Johnston; Yunge Zhao; Vanessa A Hajzus; M Reza Saadatzadeh; Gang Su; Castigliano M Bhamidipati; Gaurav S Mehta; Irving L Kron; Victor E Laubach; Michael P Murphy; Gorav Ailawadi; Gilbert R Upchurch
Journal:  Circulation       Date:  2012-09-11       Impact factor: 29.690

9.  Peptide inhibitor of CXCL4-CCL5 heterodimer formation, MKEY, inhibits experimental aortic aneurysm initiation and progression.

Authors:  Yasunori Iida; Baohui Xu; Haojun Xuan; Keith J Glover; Hiroki Tanaka; Xiaolei Hu; Naoki Fujimura; Wei Wang; Joshua R Schultz; Court R Turner; Ronald L Dalman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-01-03       Impact factor: 8.311

10.  The role of extracellular signal-related kinase during abdominal aortic aneurysm formation.

Authors:  Abhijit Ghosh; Paul D DiMusto; Lauren K Ehrlichman; Omar Sadiq; Brendan McEvoy; John S Futchko; Peter K Henke; Jonathan L Eliason; Gilbert R Upchurch
Journal:  J Am Coll Surg       Date:  2012-08-21       Impact factor: 6.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.